NCT00588094
- Conditions
- B-cell Non-Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
Clinical trial condition
Lymphoma, B-Cell
Explore clinical trials studying Lymphoma, B-Cell. Study availability and eligibility vary by location and protocol.
508 public trials
143 recruiting studies
Lymphoma, B-Cell trial results
NCT00169195
- Conditions
- Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Hôpital Henri Mondor Créteil, France
- Service d'Hématologie Clinique - CHU Le Bocage Dijon, France
- Service des Maladies du Sang - CHRU de Lille Lille, France
- Centre Léon Bérard Lyon, France
NCT00413075
- Conditions
- Adenoma, Adenosarcoma, Adnexal Diseases, +89 more
- Locations
-
- Yale New Haven Hospital New Haven, Connecticut, United States
- Columbia University - Herbert Irving Cancer Center New York, United States
- New York University Cancer Institute New York, United States
- M.D. Anderson Cancer Center Houston, Texas, United States
NCT00210314
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Oncology Institute of Southern Switzerland (IOSI) Bellinzona, Switzerland
NCT00338494
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States
Completed
Study for Evaluation of Efficacy and Safety of SH L 749 to Indolent B-cell Non-Hodgkin's Lymphoma
NCT00220285
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Nagoya, Aichi-ken, Japan
- Kashiwa-shi, Chiba, Japan
- Maebashi, Gunma, Japan
- Kanazawa, Ishikawa-ken, Japan
NCT00103779
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Stanford University Stanford, California, United States
- University of Miami Miami, Florida, United States
- Cornell University New York, United States
NCT01068392
- Conditions
- B-Cell Lymphomas, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- Dong-A University Hospital Busan, South Korea
Completed
Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL
NCT00854568
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
- Locations
-
- Fudan University Cancer Hospital Shanghai, Shanghai Municipality, China
NCT02206308
- Conditions
- B-cell Non Hodgkin's Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
Not specified